Schizophrenia: Biology and Etiology. Schizophrenia: The basics. What is schizophrenia? Good Question!!

Similar documents
GENES AND SCHIZOPHRENIA

GENETICS AND SCHIZOPHRENIA: INTRIGUING BUT CONFUSING

An Introduction to the Pharmacogenetics of Cognitive Improvement in Schizophrenia

Cognitive, affective, & social neuroscience

ESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal

Tracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health

Genetics of Behavior (Learning Objectives)

Schizoaffective Disorder

Imaging Genetics: Heritability, Linkage & Association

Clinical biomarkers for drug development in schizophrenia. Donald C. Goff, MD Nathan Kline Institute NYU School of Medicine

Schizophrenic twin. Normal twin

1 in 68 in US. Autism Update: New research, evidence-based intervention. 1 in 45 in NJ. Selected New References. Autism Prevalence CDC 2014

The relevance of D2-AKT1 signalling for the pathophysiology of cannabis-induced psychosis.

The Neurobiology of Mood and Psychotic Disorders

Introduction to the Genetics of Complex Disease

What can genetic studies tell us about ADHD? Dr Joanna Martin, Cardiff University

Use of Functional Brain Circuitry for Diagnostic and Treatment Decisions

Outline. Outline. Background Literature and Slides 10/23/2013. The Schizophrenia Research Forum online: Molecules, Neural Networks and Behavior

Identifying Youth at Clinical High Risk for Psychosis

Systems genetic evidence for a convergence of epilepsy and its co-morbidities on shared molecular pathways

The Teen Brain. Jay Giedd, MD - The Teenage Brain. Adolescence what age range? What is Adolescence. Adolescence = time of change

Genetics of Behavior (Learning Objectives)

The Neurobiology of Psychiatric Disorders

The genetics of complex traits Amazing progress (much by ppl in this room)

Mendelian & Complex Traits. Quantitative Imaging Genomics. Genetics Terminology 2. Genetics Terminology 1. Human Genome. Genetics Terminology 3

Title: Pinpointing resilience in Bipolar Disorder

Neural Development 1

Schizophrenia. Psychology 372 Physiological Psychology. Overview. Characterized by. Disorganized Thoughts Hallucinations Delusions Bizarre behaviors

Disease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland

Topography and significance of the dopaminergic dysfunction in schizophrenia

DOPAMINERGIC AND GLUTAMATERGIC DYSFUNCTIONS IN

BINGES, BLUNTS AND BRAIN DEVELOPMENT

Researchers probe genetic overlap between ADHD, autism

Genetics and Pharmacogenetics in Human Complex Disorders (Example of Bipolar Disorder)

Biological Risk Factors

COMT EFFECT ON AGGRESSION IN CHILDREN WITH & WITHOUT ADHD (British Cohort) blems (t-scores) Aggressive Behaviour Prob. n =

Jay M. Baraban MD, PhD January 2007 GENES AND BEHAVIOR

The Frontal Lobes. Anatomy of the Frontal Lobes. Anatomy of the Frontal Lobes 3/2/2011. Portrait: Losing Frontal-Lobe Functions. Readings: KW Ch.

Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans

A CONVERSATION ABOUT NEURODEVELOPMENT: LOST IN TRANSLATION

The Inheritance of Complex Traits

Title: Chapter 5 Recorded Lecture. Speaker: Amit Dhingra Created by: (remove if same as speaker) online.wsu.edu

Genetics of psychiatric disorders Dr Radwan Banimustafa

Imaging Genetics: The Example of Schizophrenia

Lecture 20. Disease Genetics

2018/05/01 DISCLOSURE EFFECTS OF CANNABIS USE IN ADOLESCENTS

The Role of Smoking in Cocaine. Addiction

Ken Winters, Ph.D. Department of Psychiatry University of Minnesota Midwest Conference on Problem Gambling August 11, 2004

Biomarkers Workshop In Clinical Trials Imaging for Schizophrenia Trials

Genes and environment: The complex etiology of psychiatric disorders

schizophrenia :The latest news By Dr. Gamal Suliman Elgorashi MB BS,DPM, MRCpsych Consultant psychiatrist Kent & Medway NHS Trust UK

Thesis. Polymorphisms in the COMT and MAOA genes and their consequences for

Cognitive Dysfunction in Schizophrenia: A Perspective from the Clinic to Genetic Brain Mechanisms

Schizophrenia. Nikita Verma 2017 Page 1

Social-Emotional Development in 22q11.2 Deletion Syndrome: Psychiatric Risk Factors

Early Detection of Childhood Schizophrenia: What This Might Mean for Our Work

APossibleRolefortheStriatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia

Experimental Medicine and Psychiatry Drug Development. John H. Krystal, M.D. Yale University

Computational Neuropharmacology

The Adolescent Developmental Stage

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director

Appendix A14.2. Neurotransmitter-Related Enzymes

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver

Biomarkers in Schizophrenia

The Neuroscience of Addiction: A mini-review

Psychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003

Chapter 18 Genetics of Behavior. Chapter 18 Human Heredity by Michael Cummings 2006 Brooks/Cole-Thomson Learning

APNA 25th Annual Conference October 19, Session 1022

The Nervous System. Neuron 01/12/2011. The Synapse: The Processor

marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD

Interaction of Genes and the Environment

Do we still believe in the dopamine hypothesis? New data bring new evidence

PSY/NEU338: Animal learning and decision making: Psychological, computational and neural perspectives

Neuroimaging of ADHD and Executive Functions

Novel Genetic Approach for the Identification of Placebo Responders A Viable Strategy for Reducing Clinical Trial Size, Cost and Time to Market

Curricular Requirement 3: Biological Bases of Behavior

marijuana and the teen brain MARY ET BOYLE, PH. D. DEPARTMENT OF COGNITIVE SCIENCE UCSD

Brain complexity and disease SM MAAS

Nature Genetics: doi: /ng Supplementary Figure 1

From maps to mechanisms through neuroimaging of schizophrenia

What Have We Learned from Molecular Imaging Studies of Dopamine Neurotransmission in Schizophrenia and in Mediating Reward Behaviors

Dan Koller, Ph.D. Medical and Molecular Genetics

Dr. Fred Rose. Schizophrenia. Nature of Schizophrenia and Psychosis: An Overview. Prevalence of Schizophrenia 10/20/10. Schizophrenia vs.

Clinical Genetics & Dementia

Psychotic Disorders and their Treatment

Index. Index. More information

The Scarlet Gene. n December 1979, Faith Reidenbach, a

Schizophrenia What is schizophrenia? Definition, pros and cons Core symptoms, other features

Interaction of Genes and the Environment

Week 2: Disorders of Childhood

Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential

Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives

In an article in this issue, Yaakub et al. (1) report on a functional MRI (fmri) study

Curriculum Vitae. Neil David Woodward, Ph.D.

Nicotine dependence treatment: A translational research approach

Future of Days Past: Neurodevelopment and Schizophrenia

Teen Brain Maturation and Vulnerability to Drug Use: New Views from Neuroimaging

Teenagers who regularly smoke cannabis suffer long lasting brain damage and are in much greater danger of developing schizophrenia.

Psychosocial intervention to optimal treatment to patients with schizophrenia: neurocognitive perspectives

Biological Psych Schizophrenia

Transcription:

Schizophrenia: Biology and Etiology Carlsson and Lindqvist 1963 Daniel R. Weinberger, M.D. Genes, Cognition and Psychosis Program National Institute of Mental Health, NIH Bethesda, Maryland 20892 USA weinberd@mail.nih.gov Schizophrenia: The basics Schizophrenia is a serious, chronic disorder of cognition, perception, and comportment. Its onset is typically in early adulthood and it causes a lifetime of disability for most affected individuals. According to the World Health Organization, it is one of the ten most disabling illnesses of human beings. The estimated economic costs in the USA alone are in excess of 50 Billion Dollars/year. What is schizophrenia? Good Question!! Schizophrenia is a syndrome, i.e. a collection of phenomenological characteristics, likely comprised of multiple etiologies with a common clinical endpoint (e.g. like MR, autism, heart failure) The syndrome is somewhat mutable: Symptoms often appear and alter over time Considerable diversity of symptoms across patients

Schizophrenia: The essentials (ca.. 2000) Genes collectively account for most variance in risk Environmental adversity in early development accounts for a small increase in risk Abnormal function of frontal and temporal cortical circuitry is associated with being ill and with increased genetic risk of being ill Subtle abnormalities in neuronal architecture are associated with being ill Antidopaminergic drugs are therapeutic Cognitive deficits in first-episode patients vs. chronic patients 2.0 Meta-Analytic First Episode 1.5 1.0 0.5 0.0 FSIQ Verbal Memory Visual Memory WCST Digit Span Trails A Trails B Block Design Vocabulary Fluency Effect Size (d) Motor Bilder RM, et al. AJP. 2000;157:549-59. 59. Heinrichs RW, Zakzanis KK. Neuropsychology. 1998;12:426-45. Intrapair differences in cognition account for the variance in social and vocational function in MZ twins concordant for schizophrenia Stepwise regression: Memory quotient+iq+card Sort+ Trails A R 2 = 0.99 GAS (social and vocational functioning) Goldberg TE, et al. Schiz Res. 1997;17:77-84.

The prefrontal response in schizophrenia is abnormal: Either too little or too much Underactive ( hypofrontal( hypofrontal ) Overactive ( inefficient( inefficient ) Meyer-Lindenberg A, et al. Amer J Psychiatry. 2001;158:1809-17. Callicott JH, al. Cerebral Cortex. 2000;10:1078-92. Neuroimaging has helped to localize brain regions implicated in the pathogenesis of schizophrenia Dorsolateral Prefrontal Cortex 1. Clinical symptoms 2. Structural imaging findings 3. Functional imaging findings 4. +/- neuropathology Hippocampus 1. Structural imaging 2. Neuropathology 3. +/- Functional imaging Other Candidates 1. Thalamus 2. Nucleus accumbens 3. Midbrain: dopamine hypothesis 4. Papez circuit: anterior cingulate D 2 receptor binding in vitro predicts clinical doses of antipsychotic drugs Creese I, et al. Science. 1976;192:481-3.

Evidence of upregulated presynaptic striatal dopamine activity in schizophrenia 11 C-Raclopride PET 6-18 F-DOPA PET Before Amphetamine After Laurelle et al, 1997.; Laurelle et al, 2000.; Breier A, et al. PNAS. 1997;94:2569-74.; Abi-Dargham A, et al. J Neurosci. 2002;22:3708-19. Reith J, et al. PNAS. 1994;91:11561-4. Hietala J, et al. Lancet. 1995;346:1130-1. Lindstrom LH, et al. Biol Psych. 1999:46:681-8. Meyer- Lindenberg A, et al. Nature Neuroscience. 2002;5:267-71. What causes schizophrenia?? Schizophrenia is largely heritable with an important environmental component Relative risk of developing schizophrenia * Mental Health: A Report of the Surgeon General (1999) http://www.surgeongeneral.gov/library/mental health/home.html

Age boys learned to stand Developmental antecedents are well established The later boys stand during the first year of life, the greater the risk of schizophrenia Isohanni M, et al. Schiz Res. 2001;52:1-19. Increased frequency of childhood enuresis in adult patients with schizophrenia 25 20 * P<.0001 Frequency of Enuresis 15 10 λ s = 2.6 Series1 5 0 1 2 3 Patients N=211 Healthy Sibs N=234 Controls N=335 Hyde et al Brain (2008) Low SES Immigration Urbanicity Substance abuse Poor cognitive performance Schizophrenia Other psychiatric disorder Social withdrawal Older father Perinatal complications Genetic predisposition

Genes and Mental Illness: Why do we study them? Most risk for psychiatric illness is related to inheritance Genes transcend phenomenological diagnosis Genes represent mechanisms of disease Genes clarify the environment Genes identify at risk individuals Genes will help individualized treatment Genes identify biological pathways for development of new treatments Complex (i.e.multifactorial) disorders like mental illness are polygenic and genetically heterogeneous affected person unaffected nonpenetrant Goldman D, et al. Nat Rev Gen. 2005;6:521-32.

The genome sequence contains many variations } Single nucleotide polymorphism AATCC AAGCC Genes are found by association A gene is said to be associated with a trait (e.g. an illness) when a variant in the gene is found with increased frequency in a population enriched with that trait A population lacking the BLUE trait aa CC Aa Cc aa Cc aa cc aa cc aa cc Aa CC AA cc genotype male female A population of BLUE people AA CC aa Cc Aa Cc AA cc AA cc Aa cc AA CC Aa cc The A gene is associated with the BLUE trait Schizophrenia susceptibility genes: Strength of the evidence GAD1 2q31.1 ++ ++++ Yes +++ ERBB4 2q34 ++ +++ Yes ++ FEZ1 11q24.2 ++ +++ Yes + MUTED 6p24.3 ++++ ++++ +++ Yes MRDS1 (OFCC1) 6p24.3 ++ ++++ + Not known After: Harrison PH, Weinberger DR. Mol Psych. 2005;10:40-68. Modified by: Straub RE, Weinberger DR. Biol Psych. 2006;60:81-3.

Are the genetic associations valid? NO: there are too many inconsistencies YES: inconsistencies would be expected The GWA approach: 20,142 subjects Hmmmm. O Donovan et al Nat Gen 2008

The Wisconsin Card Sorting Task Two Questions: 1.Why are genes for psychiatric disorders so controversial? 2. Why are the clinical associations so weak? One Answer: Genes do not encode psychiatric phenomena The path from here to there cognition Schizophrenia temperament Genes: Cells: Systems: Behavior: multiple susceptibility alleles each of small effect subtle molecular abnormalities abnormal information processing complex functional interactions and emergent phenomena The path from changes in the score (DNA code) to changes in the music (behavior) ~ ~ ~ Broken synapse orchestra Genes: multiple susceptibility alleles each of small effect Cells: subtle synaptic molecular abnormalities Distributed Neural Systems: abnormal information processing Perturbed Cognition: as an emergent phenomena

The Wisconsin Card Sorting Task The path from here to there cognition Schizophrenia temperament Genes: Cells: Systems: Behavior: multiple susceptibility alleles each of small effect subtle molecular abnormalities abnormal information processing complex functional interactions and emergent phenomena Working memory deficits and genetic risk for schizophrenia N Back Percent Correct 120 100 80 60 40 20.001.001 control sib index n=88 n=130 n=126 0 0 Back 1 Back 2 Back Goldberg TE, et al. Arch Gen Psych. 2003;60:889-96. Abnormal prefrontal efficiency and response variability: A schizophrenia intermediate phenotype fmri Patients > Controls (N=13) (N=18) Callicott et al. Cereb Cortex 2000 Healthy Siblings > Controls (N=48) (N=33) Callicott et al. Am J Psychiatry 2003 Noise Power (µv) 148.5 51.5 Controls (N=89) Delta 0.5-5.5 Hz Unaffected Siblings of (N=115) R L Schizophrenia Patients (N=66) EEG Noise Power (µv) 130.0 45.0 Controls (N=89) Theta 6.0-8.0 Hz Unaffected Siblings of (N=115) Schizophrenia Patients (N=66) R L Winterer G, et al. Am J Psychiatry. 2003;161-490-500.

The Wisconsin Card Sorting Task The path from here to there cognition Schizophrenia temperament Genes: Cells: Systems: Behavior: multiple susceptibility alleles each of small effect subtle molecular abnormalities Inefficient prefrontal engagement during executive cognition complex functional interactions and emergent phenomena Schizophrenia susceptibility genes: Strength of the evidence GAD1 2q31.1 ++ ++++ Yes +++ ERBB4 2q34 ++ +++ Yes ++ FEZ1 11q24.2 ++ +++ Yes + MUTED 6p24.3 ++++ ++++ +++ Yes MRDS1 (OFCC1) 6p24.3 ++ ++++ + Not known After: Harrison PH, Weinberger DR. Mol Psych. 2005;10:40-68. Modified by: Straub RE, Weinberger DR. Biol Psych. 2006;60:81-3. From the lab manual of Julie Axelrod

COMT affects cortical function N=126 healthy individuals p<.0001 Meyer-Lindenberg A, Weinberger DR. Nature Rev Neurosci. 2006;7:818-27. Why does COMT not have a more obvious at the behavioral level? Answer: maybe the environment matters! Genes interact with the environment to modify the expression of their individual effects. This can lead to exaggerated, compensated, or novel effects.

A gene-environment environment interaction and risk for schizophrenia psychosis: COMT and adolescent cannabis use cannabis - cannabis + Caspi et al Biol Psych 2005 No one has only one gene. Genes interact to modify the expression of their individual effects. This can lead to exaggerated, compensated, or novel effects. Genetic association in high risk context fmri 77 high risk offspring of schizophrenic parents followed > 10 years 11 developed schizophrenia Val allele associated with increased risk (p < 0.01), VV odds ratio = 8 McIntosh AM, et al. Biol Psychiatry. 2007;61:1127-34.

COMT background affects schizophrenia risk associated with inheritance of other susceptibility alleles* COMT = VV COMT = MM gene marker 320 families 68 families 54 families GAD1 P3433 ns p= 0.03* ns GAD1 P3023 ns 0.03 ns GAD1 P3248 0.02 0.004 ns DAOA (G72)P2323 0.04 0.04 ns DISC1 P3304 0.01 0.005 ns GRM3 P2878 0.02 0.04 ns 0.07 dysbindin P3762 0.03 dysbindin P2555 TDT PHASE results in Caucasian families; 0.03 dysbindin P1757 * p relates to excessive transmissions to 0.02 dysbindin affected P1578 offspring with COMT val/val genotype 0.005 viz. Nicodemus KK, al. Hum Gen. 2006;120:889-906. Straub RE, et al. Mol Psych. 2007;12:854-69. 22q11 Hemideletion Syndrome: Velo-Cardio Cardio-Facial Syndrome (VCFS) Specific recurrent CNVs are found in 2% of patients with the diagnosis of schizophrenia ISC Nat Genetics 2008

Chromosomal anomalies and schizophrenia: What do they tell us? So far, recurrent CNVs that are found with increased frequency in populations with the diagnosis of schizophrenia characterize about 2% of individuals with this diagnosis. None of these CNVs are specific for this diagnosis or even most commonly associated with this diagnosis. The most frequent association is mental deficiency. As with autism, there are multiple pathways to the diagnosis. Are psychotic individuals with these CNVs cases of schizophrenia? It is important to remember that schizophrenia is not something someone has. it is a diagnosis someone is given. Genetics and the Future of Psychiatry Where will genes take us? valid diagnosis? primary prevention? mechanisms of disease? improved outcome? new therapeutic targets? Effect of COMT val/met genotype and cognitive response to clozapine N=86 Woodward et al Schiz Res 2007

GCAP Investigators Neuroimaging Joseph Callicott Venkatta Mattay Hao-Yang Tan Andreas Meyer-Lindenberg Clinical genetics Michael Egan Terry Goldberg Lewellyn Bigelow Jose Apud Thomas Hyde Stefano Marenco Kristin Nicodemus Molecular genetics Richard Straub Bhaskar Kolachana Krishna Vakkalanka Schizophrenia Biology and Genetics: Conclusions Schizophrenia is associated with early developmental antecedents that suggest delayed and potentially deficient brain maturation. Genes tell us what the disorder is at a basic cellular level. The current evidence converges on subtle molecular bottlenecks in diverse aspects of synaptic processing and brain development. Many schizophrenia susceptibility genes, despite their diverse effects at the cellular level, impact on a common pattern of prefrontal cortical function, and most risk alleles are associated with relatively less efficient engagement of prefrontal circuitry (i.e. poorer STN), perhaps in part via altered DA signaling. Schizophrenia Biology and Genetics: Conclusions (Cont.) Rare cases with the diagnosis of schizophrenia have pathogenic structural chromosomal variations. The clinical application of gene discovery will require deep understanding of genetic variation, gene processing, molecular pathways, and the interacting environment.